buprenorphine and naloxone
Generic: buprenorphine and naloxone
Labeler: redpharm drugDrug Facts
Product Profile
Brand Name
buprenorphine and naloxone
Generic Name
buprenorphine and naloxone
Labeler
redpharm drug
Dosage Form
FILM
Routes
Active Ingredients
buprenorphine hydrochloride 2 mg/1, naloxone hydrochloride dihydrate .5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
67296-2063
Product ID
67296-2063_4b54bad7-9105-51e9-e063-6294a90a8d8c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA211785
DEA Schedule
ciii
Listing Expiration
2027-12-31
Marketing Start
2020-04-17
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
672962063
Hyphenated Format
67296-2063
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
buprenorphine and naloxone (source: ndc)
Generic Name
buprenorphine and naloxone (source: ndc)
Application Number
ANDA211785 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/1
- .5 mg/1
Packaging
- 30 POUCH in 1 CARTON (67296-2063-3) / 1 FILM in 1 POUCH
- 6 POUCH in 1 CARTON (67296-2063-6) / 1 FILM in 1 POUCH
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["BUCCAL", "SUBLINGUAL"], "spl_id": "4b54bad7-9105-51e9-e063-6294a90a8d8c", "openfda": {"unii": ["56W8MW3EN1", "5Q187997EE"], "rxcui": ["1010600"], "spl_set_id": ["300ae3d0-464c-d0be-e063-6294a90a7f9d"], "manufacturer_name": ["Redpharm Drug"]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 CARTON (67296-2063-3) / 1 FILM in 1 POUCH", "package_ndc": "67296-2063-3", "marketing_start_date": "20200417"}, {"sample": false, "description": "6 POUCH in 1 CARTON (67296-2063-6) / 1 FILM in 1 POUCH", "package_ndc": "67296-2063-6", "marketing_start_date": "20200417"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "67296-2063_4b54bad7-9105-51e9-e063-6294a90a8d8c", "dosage_form": "FILM", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "67296-2063", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "Redpharm Drug", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": ".5 mg/1"}], "application_number": "ANDA211785", "marketing_category": "ANDA", "marketing_start_date": "20200417", "listing_expiration_date": "20271231"}